Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renin inhibitors

S H Rosenberg1

  • 1Aging and Degenerative Disease Research, Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064, USA.

Progress in Medicinal Chemistry
|January 1, 1995
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).

Cell death & disease·2015
Same author

Bcl-2 family proteins are essential for platelet survival.

Cell death and differentiation·2007
Same author

New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models.

Journal of medicinal chemistry·2001
Same author

Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells.

Neoplasia (New York, N.Y.)·2001
Same author

A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.

Cancer research·2001
Same author

Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines.

European journal of cancer (Oxford, England : 1990)·2000
Same journal

The rise of AlphaFold in drug design.

Progress in medicinal chemistry·2025
Same journal

Drug design strategies for the selective targeting of lung, liver and kidney.

Progress in medicinal chemistry·2025
Same journal

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives.

Progress in medicinal chemistry·2024
Same journal

Another decade of antimalarial drug discovery: New targets, tools and molecules.

Progress in medicinal chemistry·2024
Same journal

Harnessing conformational drivers in drug design.

Progress in medicinal chemistry·2024
Same journal

Biophysical screening and characterisation in medicinal chemistry.

Progress in medicinal chemistry·2023
See all related articles